Have a personal or library account? Click to login
Downregulation of tumor-suppressor gene LHX6 in cancer: a systematic review Cover

References

  1. 1. GRIGORIOU M., TUCKER AS., SHARPE PT., PACHNIS V. Expression and regulation of Lhx6 and Lhx7, a novel subfamily of LIM homeodomain encoding genes, suggests a role in mammalian head development. Development. 1998; 125(11):2063-2074.10.1242/dev.125.11.20639570771
  2. 2. ESTÉCIO MRH., YOUSSEF EM., RAHAL P., FUKUYAMA EE., GÓIS-FILHO JF., MANIGLIA JV., et al. LHX6 is a sensitive methylation marker in head and neck carcinomas. Oncogene. 2006; 25:5018-5026.10.1038/sj.onc.120950916732332
  3. 3. PERRENOUD Q., GEOFFROY H., GAUTHIER B., RANCILLAC A., ALFONSI F., KESSARIS N., et al. Characterization of type I and type II nNOS-Expressing interneurons in the barrel cortex of mouse. Front Neural Circuits. 2012; 6:36.10.3389/fncir.2012.00036338649222754499
  4. 4. NEVES G., SHAH MM., LIODIS P., ACHIMASTOU A., DENAXA M., ROALFE G., et al. The LIM homeodomain protein Lhx6 regulates maturation of interneurons and network excitability in the mammalian cortex. Cereb Cortex. 2013; 23(8):1811–1823.10.1093/cercor/bhs159369836522710612
  5. 5. PASCHOU P., STYLIANOPOULOU E., KARAGIANNIDIS I., RIZZO R., TARNOK Z., WOLANCZYK T., et al. Evaluation of the LIM homeobox genes LHX6 and LHX8 as candidates for Tourette syndrome. Genes Brain Behav. 2012; 11(4):444-451.10.1111/j.1601-183X.2012.00778.x22435649
  6. 6. ALIFRAGIS P., LIAPI A., PARNAVELAS JG. Lhx6 regulates the migration of cortical interneurons from the ventral telencephalon but does not specify their GABA phenotype. J Neurosci. 2004; 24(24):5643–5648.10.1523/JNEUROSCI.1245-04.2004672933715201337
  7. 7. FLANDIN P., ZHAO Y., VOGT D., JEONG J., LONG J., POTTER G., et al. Lhx6 and Lhx8 coordinately induce neuronal expression of Shh that controls the generation of interneuron progenitors. Neuron. 2011; 70(5):939–950.10.1016/j.neuron.2011.04.020315340921658586
  8. 8. SUSSEL L., MARIN O., KIMURA S., RUBENSTEIN JL. Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: evidence for a transformation of the pallidum into the striatum. Development. 1999; 126(15):3359–3370.10.1242/dev.126.15.335910393115
  9. 9. SANDBERG M., FLANDIN P., SILBERBERG S., SU-FEHER L., PRICE JD., HU JS., et al. Transcriptional networks controlled by NKX2-1 in the development of forebrain GABAergic neurons. Neuron. 2016; 91(6):1260–1275.10.1016/j.neuron.2016.08.020531985427657450
  10. 10. KIM TG., YAO R., MONNELL T., CHO JH., VASUDEVAN A., KOH A., et al. Efficient specification of interneurons from human pluripotent stem cells by dorsoventral and rostrocaudal modulation. Stem Cells. 2014; 32(7):1789–1804.10.1002/stem.1704414772024648391
  11. 11. ZHAO Y., FLANDIN P., VOGT D., BLOOD A., HERMESZ E., WESTPHAL H., et al. Ldb1 is essential for development of Nkx2.1 lineage derived GABAergic and cholinergic neurons in the telencephalon. Dev Biol. 2014; 385(1):94-106.10.1016/j.ydbio.2013.10.010388289224157949
  12. 12. NAT R., SALTI A., SUCIU L., STRÖM S., DECHANT G. Pharmacological modulation of the hedgehog pathway differentially affects dorsal/ventral patterning in mouse and human embryonic stem cell models of telencephalic development. Stem Cells Dev. 2012; 21(7):1016–1046.10.1089/scd.2011.027122204396
  13. 13. ZHAO Y., FLANDIN P., LONG JE., CUESTA MD., WESTPHAL H., RUBENSTEIN JL. Distinct molecular pathways for development of telencephalic interneuron subtypes revealed through analysis of Lhx6 mutants. J Comp Neurol. 2008; 510(1):79–99.10.1002/cne.21772254749418613121
  14. 14. DU T., XU Q., OCBINA PJ., ANDERSON SA. NKX2.1 specifies cortical interneuron fate by activating Lhx6. Development. 2008; 135(8):1559-1567.10.1242/dev.01512318339674
  15. 15. GEORGIEV D., GONZÁLEZ-BURGOS G., KIKUCHI M., MINABE Y., LEWIS DA., HASHIMOTO T. Selective expression of KCNS3 potassium channel α-subunit in parvalbumin-containing GABA neurons in the human prefrontal cortex. PLoS One. 2012; 7(8): e43904.10.1371/journal.pone.0043904342716722937123
  16. 16. JAKOVCEVSKI I., MAYER N., ZECEVIC N. Multiple origins of human neocortical interneurons are supported by distinct expression of transcription factors. Cereb Cortex. 2011; 21(8):1771-1782.10.1093/cercor/bhq245313851121139075
  17. 17. CESARIO JM., MALT AL., DEACON LJ., SANDBERG M., VOGT D., TANG Z., et al. Lhx6 and Lhx8 promote palate development through negative regulation of a cell cycle inhibitor gene, p57Kip2. Hum Mol Genet. 2015; 24(17):5024-5039.10.1093/hmg/ddv223452749526071365
  18. 18. ZHAO M., GUPTA V., RAJ L., ROUSSEL M., BEI M. A network of transcription factors operates during early tooth morphogenesis. Mol Cell Biol. 2013; 33(16): 3099-3112.10.1128/MCB.00524-13375389723754753
  19. 19. ZHANG Z., GUTIERREZ D., LI X., BIDLACK F., CAO H., WANG J., et al. The LIM homeodomain transcription factor LHX6: a transcriptional repressor that interacts with pituitary homeobox 2 (PITX2) to regulate odontogenesis. J Biol Chem. 2013; 288(4):2485-2500.10.1074/jbc.M112.402933355491723229549
  20. 20. DENAXA M., SHARPE PT., PACHNIS V. The LIM homeodomain transcription factors Lhx6 and Lhx7 are key regulators of mammalian dentition. Dev Biol. 2009; 33(2):324-336.10.1016/j.ydbio.2009.07.001273895219591819
  21. 21. ARANY S., NAKATA A., KAMEDA T., KOYOTA S., UENO Y., SUGIYAMA T. Phenotype properties of a novel spontaneously immortalized odontoblast-lineage cell line. Biochem Biophys Res Commun. 2006; 342(3):718-724.10.1016/j.bbrc.2006.02.02016494847
  22. 22. PRIAM F., RONCO V., LOCKER M., BOURD K., BONNEIFOIX M., DUCHÊNE T., et al. New cellular models for tracking the odontoblast phenotype. Arch Oral Biol. 2005; 50(2):271-277.10.1016/j.archoralbio.2004.10.00715721161
  23. 23. ZHANG Y., MORI T., TAKAKI H., TAKEUCHI M., ISEKI K., HAGINO S., et al. Comparison of the expression patterns of two LIM-homeodomain genes, Lhx6 and L3/Lhx8, in the developing palate. Orthod Craniofac Res. 2002; 5(2):65-70.10.1034/j.1600-0544.2002.02198.x12086327
  24. 24. MOHER D., LIBERATI A., TETZLAFF J., ALTMAN DG., PRISMA GROUP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097.10.1371/journal.pmed.1000097270759919621072
  25. 25. YANG J., HAN F., LIU W., ZHANG M., HUANG Y., HAO X., et al. LHX6, an independent prognostic factor, inhibits lung adenocarcinoma progression through transcriptional silencing of β-catenin. J Cancer. 2017; 8(13):2561-2574.10.7150/jca.19972559508628900494
  26. 26. HU Z., XIE L. LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt/β-catenin signaling pathway. Mol Med Rep. 2015; 12(3):4634-4639.10.3892/mmr.2015.399726129710
  27. 27. LIU W-B., JIANG X., HAN F., LI Y-H., CHEN H-Q., LIU Y., et al. LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer. Cell Death Dis. 2013; 4(10):e882.10.1038/cddis.2013.366382467524157876
  28. 28. JUNG S., JEONG D., KIM J., YI L., KOO K., LEE J., et al. Epigenetic regulation of the potential tumor suppressor gene, hLHX6.1, in human cervical cancer. Int J Oncol. 2011; 38(3):859-869.10.3892/ijo.2011.904
  29. 29. JUNG S., JEONG D., KIM J., YI L., KOO K., LEE J., et al. The role of hLHX6-HMR as a methylation biomarker for early diagnosis of cervical cancer. Oncol Rep. 2010; 23(6):1675-1682.10.3892/or_00000811
  30. 30. LIAO J., LIN J., LIN D., ZOU C., KURATA J., LIN R., HE Z., SU Y. Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression. Sci Rep. 2017; 7(1):781.10.1038/s41598-017-00901-6542970728396596
  31. 31. LIN CJ., GRANDIS JR., CAREY TE., GOLLIN SM., WHITESIDE TL., KOCH WM., et al. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head and Neck. 2007; 29(2):163-188.10.1002/hed.2047817312569
  32. 32. HOLLIDAY DL., SPEIRS V. Choosing the right cell line for breast cancer research. Breast Cancer Res. 2011; 13(4):215.10.1186/bcr2889323632921884641
  33. 33. HARRIS CP., LU XY., NARAYAN G., SINGH B., MURTY VVVS., RAO PH. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosome Cancer. 2003; 36(3):233-241.10.1002/gcc.1015812557223
  34. 34. GAZDAR AF., GIRARD L., LOCKWOOD WW., LAM WL., MINNA JD. Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst. 2010; 102(17):1310-1321.10.1093/jnci/djq279293547420679594
  35. 35. NANNI P., DE GIOVANNI C., LOLLINI PL., NICOLETTI G., PRODI G. TS/A: A new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma. Clin Exp Metastasis. 1983; 1(4):373-380.10.1007/BF001211996546207
  36. 36. GHARIB A., FAEZIZADEH Z., MESBAH-NAMIN SAR., SARAVANI R. Experimental treatment of breast cancer-bearing BALB/c mice by artemisinin and transferrin-loaded magnetic nanoliposomes. Pharmacogn Mag. 2015; 11(Suppl 1):S117-S122.10.4103/0973-1296.157710446195026109756
DOI: https://doi.org/10.2478/rjim-2018-0008 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 135 - 142
Submitted on: Jan 14, 2018
Published on: Aug 29, 2018
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2018 Evelyn Nathalia, Madelaine Skolastika Theardy, Sharleen Elvira, Graciella Rosellinny, Andrew Steven Liyanto, Michael Putra Utama, Anton Sumarpo, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.